AOTI, INC. is a medical technology company that specializes in advanced wound care solutions, particularly through its patented Topical Wound Oxygen (TWO2®) therapy. This non-invasive treatment is designed to promote durable healing of severe and chronic wounds, significantly reducing hospitalizations and amputations. AOTI operates primarily in the United States, with additional markets in Europe and Canada, focusing on outcomes-based care delivered directly to patients at home. The company generates revenue through Medicaid and other payer endorsements, with a significant emphasis on improving patient outcomes and reducing healthcare costs.